BioSyent Declares Third Quarter 2025 Dividend

Company Overview - BioSyent Inc. is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and healthcare products that are safe, effective, and have a proven track record of improving patient lives [2] - The company markets its products through community, specialty, and international business units to support healthcare professionals [2] Dividend Announcement - BioSyent's Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on September 15, 2025, to shareholders of record at the close of business on August 29, 2025 [1] - This dividend for the third quarter of 2025 is consistent with the second quarter 2025 dividend of $0.05 per common share [1] - The dividend qualifies as an 'eligible dividend' for Canadian income tax purposes [1] Share Information - As of the date of the press release, BioSyent has 11,260,794 common shares outstanding [3]